Physician profile
Mary Leann Smith
NPI 1114118700
$4,135.29
in general payments reported to CMS, 2019-2025
59 companies · $1,196 in 2025
The $1,196 reported for 2025 was more than what 85% of Therapeutic Radiology providers received nationally (typical 2025 total: $179).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $331 · 2020: $197 · 2021: $397 · 2022: $669 · 2023: $613 · 2024: $731 · 2025: $1,196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,525 · Education: $15.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,524.78 |
| Education | $15.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $357.68 | 2022-2025 | |
| Astrazeneca Pharmaceuticals Lp | $323.49 | 2019-2025 | Enhertu, Lynparza |
| Merck Sharp & Dohme LLC | $245.73 | 2021-2025 | Keytruda, Welireg, Lynparza |
| Incyte Corporation | $212.98 | 2021-2025 | Jakafi, Monjuvi |
| Genzyme Corporation | $189.24 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $176.36 | 2019-2025 | Iclusig, Ninlaro, Alunbrig |
| Lilly USA, LLC | $157.14 | 2023-2025 | Verzenio, Jaypirca, Retevmo |
| Abbott Laboratories | $153.52 | 2020-2021 | |
| Daiichi Sankyo INC. | $127.72 | 2020-2025 | Enhertu, Datroway |
| Bayer Healthcare Pharmaceuticals INC. | $116.41 | 2019-2025 | |
| Seagen INC. | $107.49 | 2019-2022 | |
| Pharmacosmos Therapeutics INC. | $97.34 | 2023-2025 | Monoferric |
| Regeneron Healthcare Solutions, INC. | $96.00 | 2019-2025 | Libtayo |
| Janssen Biotech, INC. | $93.47 | 2024-2025 | Rybrevant, Erleada |
| Sobi, INC | $88.20 | 2024-2025 |
Show all 59 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.